Inventor · disambiguated record
Michael Rosenblatt
Also filed as: ROSENBLATT MICHAEL · ROSENBLATT MICHAEL M
16 granted patents·2 pending applications·450 citations·filing 1982–2024
94Inventor score
Top patents by PatentIndex Score
18 records- 0192US4423037AInhibitors of peptide hormone actionGEN HOSPITAL CORP·Filed 1982·Granted Dec 27, 1983·102 cites·64 claims
- 0288US10900939B2Quality control reagents and methodsPROMEGA CORP·Filed 2019·Granted Jan 26, 2021·2 cites·18 claims
- 0388US5747456AContinuous low-dose administration of parathyroid hormone or its agonistBETH ISRAEL HOSPITAL·Filed 1996·Granted May 5, 1998·74 cites·21 claims
- 0488US4771124AParathyroid hormone antagonists with simplified synthetic methodologyMERCK & CO INC·Filed 1987·Granted Sep 13, 1988·59 cites·3 claims
- 0586US4968669AParathyroid hormone antagonistsMERCK & CO INC·Filed 1989·Granted Nov 6, 1990·55 cites·7 claims
- 0683US10247711B2Quality control reagents and methodsPROMEGA CORP·Filed 2014·Granted Apr 2, 2019·3 cites·18 claims
- 0779US5001223AParathyroid hormone antagonists with enhanced metabolic propertiesMERCK & CO INC·Filed 1989·Granted Mar 19, 1991·36 cites·2 claims
- 0877US7799757B2Analogs of parathyroid hormone and PTH-related protein as bone anabolic agentsCHOREV MICHAEL·Filed 2003·Granted Sep 21, 2010·7 cites·10 claims
- 0977US5093233AAntagonists with position 13 modificationMERCK & CO INC·Filed 1990·Granted Mar 3, 1992·43 cites·4 claims
- 1074US11692983B2Quality control reagents and methodsPROMEGA CORP·Filed 2021·Granted Jul 4, 2023·0 cites·20 claims
- 1174US10908135B2Quality control reagents and methodsPROMEGA CORP·Filed 2019·Granted Feb 2, 2021·0 cites·15 claims
- 1274US5717062ACyclic analogs of PTH and PTHrPBETH ISRAEL HOSPITAL·Filed 1995·Granted Feb 10, 1998·36 cites·16 claims
- 1371US2009226477A1Pth2 receptor selective compoundsDONG ZHENG XIN·Filed 2009·Application pending·0 cites
- 1465US2024368680A1Compositions and methods for decrosslinking biological samplesPROMEGA CORP·Filed 2024·Application pending·0 cites
- 1555US5087562AHumoral hypercalcemic factor antagonists with modification at position 13 . . .MERCK & CO INC·Filed 1990·Granted Feb 11, 1992·18 cites·3 claims
- 1642US5114843AHumoral hypercalcemic factor antagonistsMERCK & CO INC·Filed 1991·Granted May 19, 1992·10 cites·4 claims
- 1734US5087561AHumoral hypercalcemic factor antagonists modified at position 13 by biotinMERCK & CO INC·Filed 1990·Granted Feb 11, 1992·5 cites·3 claims
- 1832US7531621B1PTH2 receptor selective compoundsSOD CONSEILS RECH APPLIC·Filed 1999·Granted May 12, 2009·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Michael Rosenblatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →